Literature DB >> 29518530

Complement component 3a receptor deficiency attenuates chronic stress-induced monocyte infiltration and depressive-like behavior.

Amanda Crider1, Tami Feng1, Chirayu D Pandya1, Talisha Davis1, Ashwati Nair2, Anthony O Ahmed3, Babak Baban4, Gustavo Turecki5, Anilkumar Pillai6.   

Abstract

Major depressive disorder (MDD) is one of the most common and debilitating neuropsychiatric illnesses. Accumulating evidence suggests a potential role of the immune system in the pathophysiology of MDD. The complement system represents one of the major effector mechanisms of the innate immune system, and plays a critical role in inflammation. However, the role of complement components in MDD is not well understood. Here, we found significant increase in component 3 (C3) expression in the prefrontal cortex (PFC) of depressed suicide subjects. We tested the role of altered C3 expression in mouse model of depression and found that increased C3 expression in PFC as a result of chronic stress causes depressive-like behavior. Conversely, mice lacking C3 were resilient to stress-induced depressive-like behavior. Moreover, selective overexpression of C3 in PFC was sufficient to cause depressive-like behavior in mice. We found that C3a (activated product of C3) receptor, C3aR+ monocytes were infiltrated into PFC following chronic stress. However, C3aR knockout mice displayed significantly reduced monocyte recruitment into PFC and reduced levels of the proinflammatory cytokine IL-1β in PFC after chronic stress. In addition, C3aR knockout mice did not exhibit chronic stress-induced behavior despair. Similarly, chronic stress-induced increases in C3aR+ monocytes and IL-1β in PFC, and depressive-like behavior were attenuated by myeloid cell depletion. These postmortem and preclinical studies identify C3aR signaling as a key factor in MDD pathophysiology.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animals; Behavior; C3; Complement; Depression

Mesh:

Substances:

Year:  2018        PMID: 29518530      PMCID: PMC5967612          DOI: 10.1016/j.bbi.2018.03.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  60 in total

1.  The prefrontal cortex as a key target of the maladaptive response to stress.

Authors:  João J Cerqueira; François Mailliet; Osborne F X Almeida; Thérèse M Jay; Nuno Sousa
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

Review 2.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

3.  Microglial NLRP3 inflammasome activation mediates IL-1β-related inflammation in prefrontal cortex of depressive rats.

Authors:  Ying Pan; Xu-Yang Chen; Qing-Yu Zhang; Ling-Dong Kong
Journal:  Brain Behav Immun       Date:  2014-05-22       Impact factor: 7.217

4.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

Authors:  Johann Steiner; Hendrik Bielau; Ralf Brisch; Peter Danos; Oliver Ullrich; Christian Mawrin; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2006-12-15       Impact factor: 4.791

5.  Inflammatory and Innate Immune Markers of Neuroprogression in Depressed and Teenage Suicide Brain.

Authors:  Ghanshyam N Pandey
Journal:  Mod Trends Pharmacopsychiatry       Date:  2017-07-24

6.  Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration.

Authors:  C L Wellman
Journal:  J Neurobiol       Date:  2001-11-15

Review 7.  Cytokines as mediators of depression: what can we learn from animal studies?

Authors:  Adrian J Dunn; Artur H Swiergiel; Renaud de Beaurepaire
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

Review 8.  Cytokines and depression: the need for a new paradigm.

Authors:  Lucile Capuron; Robert Dantzer
Journal:  Brain Behav Immun       Date:  2003-02       Impact factor: 7.217

9.  Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.

Authors:  Xinhua Zhang; Yuko Kimura; Chongyun Fang; Lin Zhou; Georgia Sfyroera; John D Lambris; Rick A Wetsel; Takashi Miwa; Wen-Chao Song
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

10.  Transglutaminase 2 overexpression induces depressive-like behavior and impaired TrkB signaling in mice.

Authors:  C D Pandya; N Hoda; A Crider; D Peter; A Kutiyanawalla; S Kumar; A O Ahmed; G Turecki; C M Hernandez; A V Terry; A Pillai
Journal:  Mol Psychiatry       Date:  2016-09-13       Impact factor: 15.992

View more
  17 in total

Review 1.  The molecular and cellular mechanisms of depression: a focus on reward circuitry.

Authors:  Megan E Fox; Mary Kay Lobo
Journal:  Mol Psychiatry       Date:  2019-04-09       Impact factor: 15.992

Review 2.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

3.  Diazepam limits microglia-mediated neuronal remodeling in the prefrontal cortex and associated behavioral consequences following chronic unpredictable stress.

Authors:  Justin L Bollinger; Matthew J Horchar; Eric S Wohleb
Journal:  Neuropsychopharmacology       Date:  2020-05-26       Impact factor: 7.853

4.  IL-1R/C3aR signaling regulates synaptic pruning in the prefrontal cortex of depression.

Authors:  Man-Man Zhang; Min-Xia Guo; Qiu-Ping Zhang; Xue-Qin Chen; Na-Zhi Li; Qing Liu; Jie Cheng; Shi-Le Wang; Guang-Hui Xu; Cheng-Fu Li; Ji-Xiao Zhu; Li-Tao Yi
Journal:  Cell Biosci       Date:  2022-06-17       Impact factor: 9.584

5.  Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression.

Authors:  Huai Tao; Xia Chen; Hongfei Zhou; Jinhua Fu; Qi Yu; Yong Liu
Journal:  Front Psychol       Date:  2020-06-23

Review 6.  Mitophagy in depression: Pathophysiology and treatment targets.

Authors:  Ashutosh Tripathi; Giselli Scaini; Tatiana Barichello; João Quevedo; Anilkumar Pillai
Journal:  Mitochondrion       Date:  2021-08-31       Impact factor: 4.160

7.  Enduring neuroimmunological consequences of developmental experiences: From vulnerability to resilience.

Authors:  Jack Reddaway; Nichola M Brydges
Journal:  Mol Cell Neurosci       Date:  2020-10-14       Impact factor: 4.314

Review 8.  Neuroprotective versus Neuroinflammatory Roles of Complement: From Development to Disease.

Authors:  Marlene Kanmogne; Robyn S Klein
Journal:  Trends Neurosci       Date:  2020-11-12       Impact factor: 13.837

9.  Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression.

Authors:  Tami Feng; Ashutosh Tripathi; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-26

Review 10.  New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.

Authors:  Naotaka Izuo; Atsumi Nitta
Journal:  J Pers Med       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.